Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

18.8%

3 terminated/withdrawn out of 16 trials

Success Rate

81.3%

-5.3% vs industry average

Late-Stage Pipeline

19%

3 trials in Phase 3/4

Results Transparency

69%

9 of 13 completed trials have results

Key Signals

9 with results

Enrollment Performance

Analytics

Phase 2

6(40.0%)

Phase 1

5(33.3%)

Phase 3

2(13.3%)

N/A

1(6.7%)

Phase 4

1(6.7%)

15Total

Phase 2(6)

Phase 1(5)

Phase 3(2)

N/A(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials

NCT01531803Phase 4Terminated

Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients

Role: collaborator

NCT03249103Phase 2Completed

Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia

Role: collaborator

NCT02090556Completed

Long-term Experience With Abatacept SC in Routine Clinical Practice

Role: collaborator

NCT02493712Phase 2Completed

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

Role: collaborator

NCT02237261Phase 2Completed

Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma

Role: collaborator

NCT03179891Phase 2Completed

Study of Diazepam Buccal Film Administered in the Interictal and in the Ictal-Periictal States to Adults With Epilepsy

Role: collaborator

NCT03679975Phase 2Terminated

Riluzole Oral Soluble Film (ROSF) Swallowing Safety in Amyotrophic Lateral Sclerosis (ALS)

Role: collaborator

NCT02956746Phase 1Completed

A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines

Role: collaborator

NCT03206229Phase 1Completed

Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects

Role: collaborator

NCT01620762Phase 3Completed

Phase III Cat-PAD Study

Role: collaborator

NCT01921257Phase 2Completed

Paediatric Safety Study in Cat-PAD

Role: collaborator

NCT03124134Not ApplicableCompleted

Gelesis Glycemic Index Study

Role: collaborator

NCT01765179Phase 3Completed

Safety and Efficacy Trial of Testosterone Undecanoate

Role: collaborator

NCT01606579Phase 1Completed

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

Role: collaborator

NCT01302405Phase 1Terminated

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors

Role: collaborator

NCT01764477Phase 1Completed

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Role: collaborator

All 16 trials loaded